Clinical Trial Update: Use of Alfuzosin in Stone Treatment With ESWL [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating alfuzosin as an adjunct to ESWL for urinary stone treatment has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Calculi

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Singapore General Hospital | Conditions: Urinary Calculi | Phase 3 | Status: WITHDRAWN